Related references
Note: Only part of the references are listed.Human Beta-papillomavirus infection and keratinocyte carcinomas
Koen D. Quint et al.
JOURNAL OF PATHOLOGY (2015)
Mechanisms behind signet ring cell carcinoma formation
Yasuhisa Fukui
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
Prognostic Significance of Complex Karyotype and Monosomal Karyotype in Adult Patients With Acute Lymphoblastic Leukemia Treated With Risk-Adapted Protocols
Cristina Motllo et al.
CANCER (2014)
PAD2 Overexpression in Transgenic Mice Promotes Spontaneous Skin Neoplasia
John L. McElwee et al.
CANCER RESEARCH (2014)
Histopathologic characteristics of therapy-associated cutaneous neoplasms with vemurafenib, a selective BRAF kinase inhibitor, used in the treatment of melanoma
Kari E. Sufficool et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2014)
Citrullination regulates pluripotency and histone H1 binding to chromatin
Maria A. Christophorou et al.
NATURE (2014)
A Cbx8-Containing Polycomb Complex Facilitates the Transition to Gene Activation during ES Cell Differentiation
Catherine Creppe et al.
PLOS GENETICS (2014)
The protein arginine deiminases: Structure, function, inhibition, and disease
Kevin L. Bicker et al.
BIOPOLYMERS (2013)
DKK3 is a potential tumor suppressor gene in papillary thyroid carcinoma
De-tao Yin et al.
ENDOCRINE-RELATED CANCER (2013)
Expression and Functional Role of Sox9 in Human Epidermal Keratinocytes
Ge Shi et al.
PLOS ONE (2013)
Identification of PADI2 as a potential breast cancer biomarker and therapeutic target
John L. McElwee et al.
BMC CANCER (2012)
FRMD4A Upregulation in Human Squamous Cell Carcinoma Promotes Tumor Growth and Metastasis and Is Associated with Poor Prognosis
Stephen J. Goldie et al.
CANCER RESEARCH (2012)
RAS Mutations Are Associated With the Development of Cutaneous Squamous Cell Tumors in Patients Treated With RAF Inhibitors
Patrick A. Oberholzer et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
MacroH2A1 Regulates the Balance between Self-Renewal and Differentiation Commitment in Embryonic and Adult Stem Cells
Catherine Creppe et al.
MOLECULAR AND CELLULAR BIOLOGY (2012)
Survival in BRAF V600-Mutant Advanced Melanoma Treated with Vemurafenib
Jeffrey A. Sosman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
RAS Mutations in Cutaneous Squamous-Cell Carcinomas in Patients Treated with BRAF Inhibitors
Fei Su et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Epithelial stem cells, wound healing and cancer
Esther N. Arwert et al.
NATURE REVIEWS CANCER (2012)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Signet ring squamous cell carcinoma-the forgotten variant: case report and review of the literature
Dina El Demellawy et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2011)
E-box-independent regulation of transcription and differentiation by MYC
Iris Uribesalgo et al.
NATURE CELL BIOLOGY (2011)
Improved Survival with Vemurafenib in Melanoma with BRAF V600E Mutation
Paul B. Chapman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Incidence Estimate of Nonmelanoma Skin Cancer in the United States, 2006
Howard W. Rogers et al.
ARCHIVES OF DERMATOLOGY (2010)
Kinase-Dead BRAF and Oncogenic RAS Cooperate to Drive Tumor Progression through CRAF
Sonja J. Heidorn et al.
CELL (2010)
RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF
Poulikos I. Poulikakos et al.
NATURE (2010)
RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth
Georgia Hatzivassiliou et al.
NATURE (2010)
Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
Keith T. Flaherty et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
H-Ras Expression in Immortalized Keratinocytes Produces an Invasive Epithelium in Cultured Skin Equivalents
Melville B. Vaughan et al.
PLOS ONE (2009)
Primary Renal Cell Carcinoma in a Transplanted Kidney: Genetic Evidence of Recipient Origin
Roger Boix et al.
TRANSPLANTATION (2009)
Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours
Juergen Veeck et al.
BREAST CANCER RESEARCH (2008)
Hyperactive Ras in developmental disorders and cancer
Suzanne Schubbert et al.
NATURE REVIEWS CANCER (2007)
Roles of the transcription factor p53 in keratinocyte carcinomas
DE Brash
BRITISH JOURNAL OF DERMATOLOGY (2006)
Peptidylarginine deiminase isoforms 1-3 are expressed in the epidermis and involved in the deiminafion of K1 and filaggrin
R Nachat et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2005)
CDK4 coexpression with Ras generates malignant human epidermal tumorigenesis
M Lazarov et al.
NATURE MEDICINE (2002)
Share Paper
